Halozyme Therapeutics

Halozyme Therapeutics

World Rank (Aug-2026)
2015
Market Cap (Aug-2026)
11.198 Billion USD
World Rank (Jan-05-2024)
3,006
Market Cap (Jan-05-2024)
4.828 Billion USD
World Rank (Jul-30-2023)
2,631
Market Cap (Jul-30-2023)
5.749 Billion USD
World Rank (Jan-07-2022)
3,159
Market Cap (Jan-07-2022)
5.250 Billion USD
World Rank (Jan-01-2021)
2,635
Market Cap (Jan-01-2021)
5.774 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 891
Headquarters Country
USA
Top Technology Companies in USA
Top Healthcare Companies in USA
Nasdaq / NYSE Code
HALO
Employee Count
393
Employee Count as of Date
As on 2022
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
1,397 Million USD
Annual Operating Income in USD
469 Million USD
Annual Net Income in USD
317 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
2,525 Million USD
Total Liabilities in USD
2,477 Million USD
Total Equity in USD
49 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Technology
HealthCare Products
Company Website
HALOZYME THERAPEUTICS INC
Yahoo
Yahoo @ Nasdaq
Company Profile

Halozyme Therapeutics is a Biotechnology Company focused on novel biological and drug delivery approaches. It is having approximately 130 employees. The headquarters is in USA.

Annual Results Summary

HALOZYME THERAPEUTICS - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022660267202
Dec-2021443 275 402
Dec-2020267 144129
Dec-2019195-67-72
Dec-2018151-69-80
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,841 Million USD.

Total Liabilities as on Dec-2022 was 1,671 Million USD.

Total Equity as on Dec-2022 was 169 Million USD.

Founded Year
1998
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Share